Registered office: Russia, Irkutsk, 664007, Krasnogvardeyskaya str., 23, office 3.
Principal place of business: Rosa Luxemburg str., 184, Irkutsk, Russia
Tel.: (3952) 55-03-55
Russia, Irkutsk, 664040, P.O.B. 17
Russia, Moscow, 123100, Presnenskaya naberezhnaya, 12, Federation Tower (West), 42th floor
Tel.: +7 (495) 750-54-37
Tel. (for calls in Russia): 8 800 100 15 50
JSC Pharmasyntez is a national leading manufacturer of drugs for the treatment of socially significant diseases, such as tuberculosis, HIV, oncology, diabetes mellitus, and hepatitis.
The production facilities are represented by five modern high-tech plants in the following cities: Ussuriysk, Irkutsk, Bratsk, Tyumen, and Saint Petersburg. The company’s product portfolio comprises over 170 items of the drugs in various dosage forms: capsules, tablets, granules, infusion solutions, dry sterile powders and lyophilisates, as well as solutions for injection. More than 80% of the drugs produced are included in the list of vital and essential drugs.
The annual production volume is more than 70 million packages. At the end of 2019, the revenue amounted to 22.7 billion rubles. JSC Pharmasyntez is ranked in the top three fast-growing Russian technology companies * and included in the list of Russia’s systemically important’ companies.
*According to the National rating of fastest growing companies TechUspekh.